Pfizer buying spree continues with $5.4B deal | The Journal Record

Pfizer will spend about $5.4 billion to buy Global Blood Therapeutics as the pharmaceutical giant continues to invest some of the cash influx reaped during the COVID-19 pandemic.

Related Keywords

New York ,United States ,Aamir Malik ,Pfizer ,Pfizer Inc ,Arena Pharmaceuticals ,Reviral Ltd ,Global Blood Therapeutics ,New York City ,Global Blood ,